IN VITRO DIAGNOSTIC REAGENT FOR

Brand Owner (click to sort) Address Description
BIOCULT-GC Medical Technology Corporation 71 Veronica Ave. Somerset NJ 08873 In Vitro Diagnostic Reagent for Use with Bacterial Cultures;
CREARATE BAKER INSTRUMENTS CORPORATION P.O. BOX 2168 2196 AVENUE C BETHLEHEM PA 18001 IN VITRO DIAGNOSTIC REAGENT FOR MEDICAL LABORATORY USE;
ELECTRORATE BAKER INSTRUMENTS CORPORATION P.O. BOX 2168 2196 AVENUE C BETHLEHEM PA 18001 IN VITRO DIAGNOSTIC REAGENT FOR MEDICAL LABORATORY USE;
HEMA-PLUS BOEHRINGER MANNHEIM DIAGNOSTICS, INC. 9115 HAGUE ROAD INDIANAPOLIS IN 46250 In Vitro Diagnostic Reagent for Medical Tests;
LYSE ALYVE HENRY SCHEIN, INC. 135 DURYEA ROAD MELVILLE NY 11747 IN VITRO DIAGNOSTIC REAGENT FOR VETERINARY USE IN THE DETECTION OF HEARTWORM;LYSE ALIVE;LYSE;
MONOVAL American Hospital Supply Corporation Evanston IL In Vitro Diagnostic Reagent for Testing Blood Compatability;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. This invention is about a method for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic reagent system and diagnostic kit for the diagnosis. The method, diagnostic reagent system, and kit are based on the finding that the level of MMP-8 in the amniotic fluid is significantly higher when the pregnant woman is at risk for preterm delivery, intrauterine infection, and fetal damage. The diagnostic reagent system and kit can be applied to patients with or without clinical signs of preterm labor or premature rupture of fetal membranes. With its superiority in sensitivity and specificity as well as its less invasiveness compared to the conventional method of measuring fetal blood cytokine levels, this diagnostic reagent system and kit is very useful in the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage.